FDA warns of risks from breast implantsBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7452.1338-c (Published 03 June 2004) Cite this as: BMJ 2004;328:1338
- Roger Dobson
Women considering breast augmentation should be aware of the risk of implants rupturing and other adverse events during mammography.
Delayed detection of breast cancer and pain and discomfort are among the other risks identified in an analysis of reports received by the Food and Drug Administration.
“It is important that women considering breast implants be informed of these potential risks and that clinicians, radiologists, and mammographic technicians keep them in mind when imaging women with implants,” say the authors, from the FDA's Division of Postmarket Surveillance.
In the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial